You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Anti-PD-1/PD-L1 agents

Showing 9951 - 9975 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MRI to Predict Rejection and Failure in Transplant and

Recruiting
  • Heart Failure
  • +2 more
    • Washington, District of Columbia
      Children's National Health System
    Jul 21, 2022

    Postoperative Pain, Stress Hormone Response, Subcostal Transversus Abdominis Plane Block Trial in Sisli (Ultrasound guided

    Not yet recruiting
    • Postoperative Pain
    • +3 more
    • Ultrasound guided subcostal transversus abdominis plane block
    • Wound site local anesthetic infiltration
    • Sisli, Istanbul, Turkey
      Sisli Hamidiye Etfal Training and Research Hospital
    Mar 3, 2023

    ICU Delirium Trial in Taipei (mHELP@ICU)

    Recruiting
    • ICU Delirium
    • mHELP@ICU
    • Taipei, National Taiwan University, Taiwan
      Cheryl, Chia-Hui Chen, PhD
    Sep 19, 2023

    Cardiovascular Disease Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Fx-5A peptide complex)

    Recruiting
    • Cardiovascular Disease
    • Fx-5A peptide complex
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Apr 7, 2022

    Lymphoid Malignancies Trial in United States (AVM0703)

    Recruiting
    • Lymphoid Malignancies
    • Duarte, California
    • +6 more
    Nov 14, 2022

    Hepatobiliary Tumor, Liver Tumor, Biliary Tract Tumors Trial in Beijing (axitinib plus toripalimab)

    Recruiting
    • Hepatobiliary Neoplasm
    • +2 more
    • axitinib plus toripalimab
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Aug 17, 2021

    Hepatocellular Carcinoma Trial in Guangzhou (Atezolizumab, Bevacizumab, HAIC with FOLFOX)

    Recruiting
    • Hepatocellular Carcinoma
    • Guangzhou, Guangdong, China
      Cancer Center Sun Yat-sen University
    May 24, 2023

    Locally Advanced or Metastatic Epithelial Tumor Trial in Guangzhou (SI-B001)

    Active, not recruiting
    • Locally Advanced or Metastatic Epithelial Tumor
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Mar 14, 2022

    Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma, B-cell Lymphoma Refractory Trial in Cologne,

    Active, not recruiting
    • Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
    • +3 more
    • MB-CART20.1
    • Cologne, Germany
    • +1 more
    Sep 20, 2021

    Acute Myeloid Leukemia With KMT2A Rearrangement, Acute Myeloid Leukemia With NPM1 Mutation Trial (Biospecimen Collection, Bone

    Not yet recruiting
    • Acute Myeloid Leukemia With KMT2A Rearrangement
    • Acute Myeloid Leukemia With NPM1 Mutation
    • Biospecimen Collection
    • +7 more
    • (no location specified)
    Jun 1, 2023

    Preoperative Biliary Drainage in Malignant Biliary Obstruction

    Not yet recruiting
    • Pancreatic Cancer
    • Preoperative drainage and pancreatoduodenectomy
    • Pancreatoduodenectomy
    • (no location specified)
    Apr 14, 2021

    Lung Cancer, Non-Small Cell, Tumors Trial in Nashville, Madrid (Tumor biopsy)

    Recruiting
    • Lung Cancer, Non-Small Cell
    • Neoplasms
    • Tumor biopsy
    • Nashville, Tennessee
    • +1 more
    Aug 11, 2022

    MDS, Acute Myeloid Leukemia Trial in Australia, France, Germany (Imetelstat)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • Acute Myeloid Leukemia
    • Adelaide, Australia
    • +11 more
    Oct 13, 2022

    CKD Mother Patient in Sohag Governorate

    Recruiting
    • CKD PREGNANT WOMEN
    • Serum creatinine
    • +6 more
    • Sohag, Egypt
      Sohag university hospital
    May 10, 2023

    Relapsing Multiple Sclerosis Trial in Fort Collins, Farmington (Ublituximab)

    Recruiting
    • Relapsing Multiple Sclerosis
    • Ublituximab
    • Fort Collins, Colorado
    • +1 more
    May 26, 2023

    Uveitis Related Cystoid Macular Edema, Steroid-induced Glaucoma - Borderline Trial in London (Ranibizumab)

    Completed
    • Uveitis Related Cystoid Macular Edema
    • Steroid-induced Glaucoma - Borderline
    • London, United Kingdom
      Moorfields Eye Hospital NHSFT Research and Treatment Centre
    Mar 25, 2019

    Rotator Cuff Tear Trial in Germany, Switzerland (arthroscopic rotator cuff reconstruction)

    Recruiting
    • Rotator Cuff Tear
    • arthroscopic rotator cuff reconstruction
    • Berlin, Germany
    • +19 more
    Feb 28, 2022

    Osteosarcoma, Survival, Chemo Effect Trial in Beijing (MAPI chemo, Apatinib Mesylate, Camrelizumab)

    Unknown status
    • Osteosarcoma
    • +3 more
    • MAPI chemotherapy
    • +2 more
    • Beijing, China
      Peking University People's Hospital
    May 15, 2020

    Idiopathic Environmental Intolerance Trial in Paris (Cognitive Behavioral Therapy)

    Not yet recruiting
    • Idiopathic Environmental Intolerance
    • Cognitive Behavioral Therapy
    • Paris, France
      Unité de pathologies professionnelles et environnementales, Hôte
    Jul 26, 2023

    Heart Transplantation Trial in Los Angeles (Thymoglobulin, Mycophenolate Mofetil, Tacrolimus)

    Enrolling by invitation
    • Heart Transplantation
    • Los Angeles, California
    • +1 more
    Nov 11, 2022

    CFTR-modulating Triple Therapy Elexacaftor - Tezacaftor -

    Recruiting
    • Cystic Fibrosis
    • Elexacaftor / Ivacaftor / Tezacaftor
    • Erlangen, Bavaria, Germany
      University Hospital Erlange, Department of Pediatrics
    Oct 7, 2022

    Pain, Postoperative, Cardiac Surgery Trial (LRA Loco-regional anesthesia, Standardized post-operative analgesia protocol)

    Not yet recruiting
    • Pain, Postoperative
    • Cardiac Surgery
    • LRA Loco-regional anesthesia
    • Standardized post-operative analgesia protocol
    • (no location specified)
    Apr 25, 2022

    Advanced Colorectal Cancer Trial in Guangzhou (Activated CIK and CD3-MUC1 Bispecific Antibody in Treating colorectal cancer,

    Withdrawn
    • Advanced Colorectal Cancer
    • Activated CIK and CD3-MUC1 Bispecific Antibody in Treating colorectal cancer
    • Cryotherapy
    • Guangzhou, Guangdong, China
      Institutional Review Board of Guangzhou Fuda Cancer Hospital
    Oct 13, 2020

    Advanced Lung Cancer Trial in Guangzhou (Activated CIK and CD3-MUC1 Bispecific Antibody in Treating Lung cancer, Cryotherapy)

    Withdrawn
    • Advanced Lung Cancer
    • Activated CIK and CD3-MUC1 Bispecific Antibody in Treating Lung cancer
    • Cryotherapy
    • Guangzhou, Guangdong, China
      Institutional Review Board of Guangzhou Fuda Cancer Hospital
    Oct 13, 2020

    Advanced Gastric Cancer Trial in Guangzhou (Activated CIK and CD3-MUC1 Bispecific Antibody in Treating Gastric cancer,

    Withdrawn
    • Advanced Gastric Cancer
    • Activated CIK and CD3-MUC1 Bispecific Antibody in Treating Gastric cancer
    • Cryotherapy
    • Guangzhou, Guangdong, China
      Institutional Review Board of Guangzhou Fuda Cancer Hospital
    Oct 13, 2020